We are thrilled to congratulate our ecosystem member, Wemedoo, on successfully completing its latest funding round. This achievement paves the way for accelerated global growth and strengthens its presence in the market.
- Wemedoo AG is a Swiss-based clinical data specialist, dedicating itself to cutting-edge software systems that advance clinical research. The team is pioneering digital health innovation by breaking down barriers and achieving full interoperability, enhancing the quality, flexibility, and real-world application of healthcare data.
- With this new funding, Wemedoo is well-positioned to expand its global footprint, enhance strategic initiatives, and continue delivering advanced, reliable solutions to its partners in the healthcare industry. Wemedoo remains committed to supporting clinical trials and research with technology that simplifies and accelerates data management across the board.
- This investment not only validates Wemedoo’s business model but also reaffirms their mission: helping healthcare providers, pharmaceutical companies, and researchers manage their data more effectively and collaborate more easily. This will ultimately strengthen patient care and create real value for the healthcare sector.
We commend the entire Wemedoo team for this remarkable achievement and are excited to support their journey.